Ruiyuan H. Cao

27 Taiping Road
Taiping, 100850, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Ondansetron exhibits potent antiviral activity against enterovirus 71 infection in vitro and in vivo.

Ondansetron exhibits potent antiviral activity against enterovirus 71 infection in vitro and in vivo.

Journal: Virus research

Published: April 08, 2026

Identification of novel non-covalent Mpro inhibitors against SARS-CoV-2 by the computational and experimental approaches.

Identification of novel non-covalent Mpro inhibitors against SARS-CoV-2 by the computational and experimental approaches.

Journal: Journal of molecular graphics & modelling

Published: July 08, 2025

Identification of novel inhibitors of dengue viral NS5 RNA-dependent RNA polymerase through molecular docking, biological activity evaluation and molecular dynamics simulations.

Identification of novel inhibitors of dengue viral NS5 RNA-dependent RNA polymerase through molecular docking, biological activity evaluation and molecular dynamics simulations.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: February 12, 2025

TRPM4 channels contribute to Adriamycin chemoresistance in breast cancer cells.

TRPM4 channels contribute to Adriamycin chemoresistance in breast cancer cells.

Journal: European journal of pharmacology

Published: November 24, 2024

Fangchinoline Inhibits Zika Virus by Disrupting Virus Internalization.

Fangchinoline Inhibits Zika Virus by Disrupting Virus Internalization.

Journal: ACS infectious diseases

Published: November 13, 2024

Discovery of novel inhibitors of dengue viral RNA-dependent RNA polymerase by molecular docking, in vitro assay, DFT, and MD simulations.

Discovery of novel inhibitors of dengue viral RNA-dependent RNA polymerase by molecular docking, in vitro assay, DFT, and MD simulations.

Journal: International journal of biological macromolecules

Published: October 15, 2024

Identification of novel SARS-CoV-2 3CLpro inhibitors by molecular docking, in vitro assays, molecular dynamics simulations and DFT analyses.

Identification of novel SARS-CoV-2 3CLpro inhibitors by molecular docking, in vitro assays, molecular dynamics simulations and DFT analyses.

Journal: Frontiers in pharmacology

Published: September 11, 2024

The novel COVID-19 treatment VV116 is a potential inhibitor of Zika virus.

The novel COVID-19 treatment VV116 is a potential inhibitor of Zika virus.

Journal: Virology

Published: August 27, 2024

The Synergistic Effect of Baloxavir and Neuraminidase Inhibitors against Influenza Viruses In Vitro.

The Synergistic Effect of Baloxavir and Neuraminidase Inhibitors against Influenza Viruses In Vitro.

Journal: Viruses

Published: August 11, 2024

Antiviral Activity of Selective Estrogen Receptor Modulators against Severe Fever with Thrombocytopenia Syndrome Virus In Vitro and In Vivo.

Antiviral Activity of Selective Estrogen Receptor Modulators against Severe Fever with Thrombocytopenia Syndrome Virus In Vitro and In Vivo.

Journal: Viruses

Published: June 27, 2024

A skin organoid-based infection platform identifies an inhibitor specific for HFMD.

A skin organoid-based infection platform identifies an inhibitor specific for HFMD.

Journal: Nature communications

Published: June 24, 2024

Gene Therapy with Enterovirus 3 C Protease: A Promising Strategy for Various Solid Tumors.

Gene Therapy with Enterovirus 3 C Protease: A Promising Strategy for Various Solid Tumors.

Journal: Nature communications

Published: May 31, 2024

Showing 1-12 of 67

Last Updated: 09/26/2026